Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Prospective Comparison on Cardiac and Hepatic Iron and Cardiac Function by MR in Thalassemia Major Patients Treated with Combination Deferiprone–Desferrioxamine Versus Deferiprone and Desferrioxamine in Monoterapy,

Alessia Pepe, Antonella Meloni, PhD, Pasquale Pepe, Marcello Capra, M.D., Domenico Giuseppe D'Ascola, Michele Santodirocco, Paolo Cianciulli, M.D., Vincenzo Caruso, M.D., Maria Antonietta Romeo, M.D., Aldo Filosa, Lorella Pitrolo, Maria Caterina Putti, MD, Aurelio Maggio, MD, Massimiliano Missere, Vincenzo Positano, Massimo Lombardi, Paolo Ricchi

Blood (2011) 118 (21): 3194.

https://doi.org/10.1182/blood.V118.21.3194.3194

Published: 2011

Journal Articles

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Blood (2011) 118 (21): 3197.

https://doi.org/10.1182/blood.V118.21.3197.3197

Published: 2011

Journal Articles

Diabetes Mellitus and Cardiac Complications in Thalassemia Major Patients

Maria Rita Gamberini, Antonella Meloni, PhD, Vincenzo Caruso, M.D., Marcello Capra, M.D., Paolo Cianciulli, M.D., Aurelio Maggio, MD, Elisabetta Chiodi, Massimo Lombardi, Alessia Pepe

Blood (2011) 118 (21): 2150.

https://doi.org/10.1182/blood.V118.21.2150.2150

Published: 2011

Journal Articles

Different Patterns of Myocardial Iron Overload by T2* Cardiovascular MR As Markers of Risk for Cardiac Complication in Thalassemia Major,

Antonella Meloni, PhD, Pasquale Pepe, Petra Keilberg, Brunella Favilli, Vincenzo Positano, Marcello Capra, Vincenzo Caruso, M.D., Paolo Cianciulli, Aldo Filosa, Angelo Zuccarelli, Lucia De Franceschi, MD, Massimo Lombardi, Alessia Pepe

Blood (2011) 118 (21): 3190.

https://doi.org/10.1182/blood.V118.21.3190.3190

Published: 2011

Journal Articles

Prospective Survey on Heart and Liver Iron and Heart Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine Versus Deferiprone and Desferrioxamine in Monotherapy

Alessia Pepe, Antonella Meloni, PhD, Giuseppe Rossi, Anna Spasiano, Domenico Giuseppe D'Ascola, Aldo Filosa, Vincenzo Caruso, M.D., Paolo Cianciulli, M.D., Maria Antonietta Romeo, M.D., Maria Caterina Putti, MD, Angelo Peluso, Maria Grazia Bisconte, Maria Eliana Lai, Aurelio Maggio, MD, Cristina Salvatori, Massimo Lombardi, Marcello Capra, M.D.

Blood (2011) 118 (21): 5298.

https://doi.org/10.1182/blood.V118.21.5298.5298

Published: 2011

Journal Articles

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Blood (2011) 118 (21): 5302.

https://doi.org/10.1182/blood.V118.21.5302.5302

Published: 2011

Journal Articles

Deferiprone Versus Sequential Deferiprone-Deferoxamine Treatment in Thalassemia Major: A Five Years Multicenter Randomized Clinical Trial under the Auspices of the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE).

Blood (2007) 110 (11): 575.

https://doi.org/10.1182/blood.V110.11.575.575

Published: 2007

NARROW

Prospective Comparison on Cardiac and Hepatic Iron and Cardiac Function by MR in Thalassemia Major Patients Treated with Combination Deferiprone–Desferrioxamine Versus Deferiprone and Desferrioxamine in Monoterapy,

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Diabetes Mellitus and Cardiac Complications in Thalassemia Major Patients

Different Patterns of Myocardial Iron Overload by T2* Cardiovascular MR As Markers of Risk for Cardiac Complication in Thalassemia Major,

Prospective Survey on Heart and Liver Iron and Heart Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine Versus Deferiprone and Desferrioxamine in Monotherapy

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Deferiprone Versus Sequential Deferiprone-Deferoxamine Treatment in Thalassemia Major: A Five Years Multicenter Randomized Clinical Trial under the Auspices of the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE).

Email alerts

ASH Publications

American Society of Hematology

Prospective Comparison on Cardiac and Hepatic Iron and Cardiac Function by MR in Thalassemia Major Patients Treated with Combination Deferiprone–Desferrioxamine Versus Deferiprone and Desferrioxamine in Monoterapy,

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Diabetes Mellitus and Cardiac Complications in Thalassemia Major Patients

Different Patterns of Myocardial Iron Overload by T2* Cardiovascular MR As Markers of Risk for Cardiac Complication in Thalassemia Major,

Prospective Survey on Heart and Liver Iron and Heart Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine Versus Deferiprone and Desferrioxamine in Monotherapy

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Deferiprone Versus Sequential Deferiprone-Deferoxamine Treatment in Thalassemia Major: A Five Years Multicenter Randomized Clinical Trial under the Auspices of the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only